Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting activated ...
LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile observed in masked ...
Healthy Vision Month in May is a great time for Texans to focus on protecting their vision health and preventing eye disease. To keep eyes healthy, schedule regular eye exams to check for common ...
PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology, has reported the ...
MedPage Today on MSN
VEGF Inhibitor Implant Preserves Visual Acuity, Retinal Anatomy in Wet AMD
Good baseline visual acuity retained in three-fourths of patients at 36 weeks with OTX-TKI ...
PulseSight Therapeutics has unveiled positive phase 1 results for PST‑611, its non‑viral gene therapy candidate for dry ...
Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.
Beacon Therapeutics Holdings Limited (Beacon Therapeutics or the Company), a leading clinical-stage biotechnology company ...
About Dr. James Leong: Dr. James Leong is an Oxford fellowship-trained consultant ophthalmologist specializing in medical retina, uveitis, and refractive cataract surgery. He is the founder of The Eye ...
A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved ...
When the uncle of Dr. David Rhew’s co-worker visited the emergency department with severe abdominal pain, he received a scan ...
Belite Bio (NASDAQ: BLTE) is one of the best up and coming stocks with highest upside potential. On April 21, Belite Bio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results